Literature DB >> 25166007

The heterogeneity of changes in incidence and survival among lymphoid malignancies in a 30-year French population-based registry.

Mylène Dandoit1, Morgane Mounier, Julien Guy, Tony Petrella, Stéphanie Girard, René-Olivier Casasnovas, Laurent Martin, Franck Bonnetain, Marc Maynadié.   

Abstract

Our specialized population-based registry has allowed us to explore changes in incidence and survival by subtype over the last 30 years. Between 1980 and 2009, 4790 cases of lymphoid malignancies were registered using the International Classification of Diseases for Oncology. The incidence rate of lymphoid malignancies was 20.5 per 100,000 inhabitants per year, and ranged from 0.1 to 4 according to subtype. Five-year net survival was 65%, and ranged from 41% to 93% according to subtype. We observed an increase in 5-year net survival between the periods 1980-1989 and 2000-2009 (58% vs. 70%). This was observed in most but not all subtypes. Our long-standing population-based registry allowed us to measure differences in trends according to the subtype of lymphoid malignancy. Incidence rates steadily increased in quite frequent entities, and poor survival probability for most entities indicates that they should be the next objective in therapeutic research programs.

Entities:  

Keywords:  Incidence; cancer registry; lymphoid malignancies; population-based; survival; trend

Mesh:

Year:  2014        PMID: 25166007     DOI: 10.3109/10428194.2014.956315

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  3 in total

Review 1.  Epidemiology of Follicular Lymphoma.

Authors:  James R Cerhan
Journal:  Hematol Oncol Clin North Am       Date:  2020-05-05       Impact factor: 3.722

2.  Epidemiology of Marginal Zone Lymphoma.

Authors:  James R Cerhan; Thomas M Habermann
Journal:  Ann Lymphoma       Date:  2021-03-30

3.  Association between abnormal serum free light chains ratio and known prognostic factors in lymphoma; a nephrology viewpoint.

Authors:  Minoosh Moghimi; Mahshid Kashkooli Behroozi; Mehdi Maghbooli; Sattar Jafari; Saeideh Mazloomzadeh; Aiyoub Pezeshgi
Journal:  J Renal Inj Prev       Date:  2016-12-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.